Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mahrshee Laboratories is an Indian pharmaceutical company primarily engaged in the development, manufacture, and export of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. Established in 2003 and headquartered in Ahmedabad, Gujarat, the company operates manufacturing facilities that adhere to Good Manufacturing Practice (GMP) standards. Their product portfolio focuses on high-demand therapeutic areas such as anti-diabetics, anti-hypertensives, anti-fungals, and gastrointestinal treatments. Mahrshee Laboratories emphasizes process chemistry and R&D to optimize production efficiency and ensure high-quality chemical synthesis. The company serves a global clientele, providing essential raw materials for finished dosage formulators across various international markets. Their commitment to quality and cost-effective manufacturing has established them as a reliable partner in the generic pharmaceutical supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mahrshee Laboratories.